DIAgnostic iMaging or Observation in Early Equivocal appeNDicitis (DIAMOND)

August 24, 2021 updated by: Panu Mentula, Helsinki University Central Hospital

DIAgnostic iMaging or Observation in Early Equivocal appeNDicitis - a Randomized Controlled Trial

The aim of the study is to evaluate whether patients with early equivocal appendicitis can be observed instead of immediate diagnostic imaging. Half of the patients are randomly assigned to observation group, while the other half will undergo diagnostic imaging. The hypothesis is that resolving appendicitis is common in these patients. Thus, in observation group there will be fewer patients with appendicitis diagnosis and observation reduces the use of diagnostic imaging and surgery.

Study Overview

Status

Completed

Conditions

Detailed Description

For the study equivocal appendicitis is defined as clinical suspicion of appendicitis with Adult Appendicitis Score between 11 and 15. The estimated prevalence of appendicitis in such patients is around 50%.

Diagnostic imaging is done using conditional computed tomography i.e. abdominal ultrasound first and computed tomography only after negative or inconclusive appendicitis after ultrasound.

In observation group repeated clinical examination is done after 6-8 hours interval with repeated blood test for calculation of Adult Appendicitis Score. Patients with decreasing score value continue observation without imaging, whereas patients with the same score value or higher (but below 16) undergo diagnostic imaging as in other group. Laparoscopy is done without imaging in patients with high score (16 or higher). Antibiotics are not allowed, but prophylactic antibiotics during induction of anesthesia are allowed.

Study Type

Interventional

Enrollment (Actual)

185

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Helsinki, Finland, 00029
        • Helsinki University Central Hospital, Meilahti Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical suspicion of acute appendicitis
  • Equivocal appendicitis defined by Adult Appendicitis Score: Score ≥11 and ≤15.

Exclusion Criteria:

  • C-reactive protein >99 mg/l
  • Time from symptom onset over 24 hours
  • Pregnancy
  • Antibiotics given within last 24 hours
  • Suspicion of other disease than appendicitis, that would require immediate interventions such as surgery, diagnostic imaging or gynecologic consultation
  • Missing written informed consent
  • Patient randomized earlier to the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Observation
Clinical follow-up for at least 6-8 hours, after follow-up repeated laboratory tests and repeated clinical examination is done. Adult Appendicitis Score is calculated after observation to determine further actions. Observation is continued in patients with decreasing score. Patients with the same or higher score undergo diagnostic imaging (score 11-15) or laparoscopy (score 16 or higher). Diagnostic imaging is abdominal ultrasound first and if the result is inconclusive or negative for appendicitis abdominal computed tomography is done. Laparoscopic appendectomy is done for those patients with appendicitis in diagnostic imaging.
Observation for 6 to 8 hours. After observation period repeated clinical examination and repeated blood test for calculation of Adult Appendicitis Score is done.
Active Comparator: Diagnostic imaging
Patients undergo abdominal ultrasound and if the result is inconclusive or negative for appendicitis patients will have abdominal computed tomography. Laparoscopic appendectomy is done for patients with appendicitis in diagnostic imaging.
Abdominal ultrasound, followed by abdominal computed tomography when necessary

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Appendicitis requiring surgery or other intervention
Time Frame: 30 days from randomization
30 days from randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complicated appendicitis
Time Frame: 30 days from randomization
Perforated appendicitis or appendiceal abscess
30 days from randomization
Delayed appendicitis diagnosis
Time Frame: 30 days from randomization
Diagnosis is delayed if appendicitis is diagnosed later than 24 hours from randomization
30 days from randomization
Number of diagnostic imaging studies needed
Time Frame: 30 days from randomization and within 1 year after randomization
Number of abdominal ultrasound and abdominal computed tomography per patient
30 days from randomization and within 1 year after randomization
Appendicitis requiring surgery or other intervention
Time Frame: within 1 year after randomization
within 1 year after randomization
Negative appendectomy
Time Frame: 30 days from randomization
Laparoscopy done for suspected appendicitis, but patient does not have appendicitis
30 days from randomization
Number of re-admissions to emergency unit
Time Frame: 1 year
Any reason for re-admission are accounted
1 year
Number of other clinically relevant findings
Time Frame: 30 days from randomization
Findings unrelated to appendicitis
30 days from randomization
Number of patients requiring of gynecological consultation
Time Frame: 30 days from randomization
Applicable only in female patients
30 days from randomization
Time for decision
Time Frame: 30 days from randomization
The time from randomization to either decision to operate in appendicitis patients or to discharge in non-appendicitis patients.
30 days from randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Panu J Mentula, M.D. Ph.D., Helsinki University Central Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2016

Primary Completion (Actual)

April 9, 2020

Study Completion (Actual)

April 30, 2021

Study Registration Dates

First Submitted

April 7, 2016

First Submitted That Met QC Criteria

April 13, 2016

First Posted (Estimate)

April 19, 2016

Study Record Updates

Last Update Posted (Actual)

August 25, 2021

Last Update Submitted That Met QC Criteria

August 24, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Appendicitis

Clinical Trials on Observation

3
Subscribe